Clinical Trials Directory

Trials / Completed

CompletedNCT01228071

Time to Eugonadal Range, Time to Steady State and Drying Time

Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Endo Pharmaceuticals · Industry
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, open-label, single arm trial to evaluate the time to eugonadal testosterone range after initial testosterone gel 2% application, time to steady state after after initiation of testosterone gel 2%, and drying time after application of testosterone gel 2%.

Detailed description

Assessment of Time to Eugonadal Testosterone Range After Initial Fortesta (Testosterone) Gel 2% Application, Time to Steady State After Initiation of Fortesta, And Gel Drying Time After Fortesta Application

Conditions

Interventions

TypeNameDescription
DRUGtestosterone gel 2%40 mg testosterone gel 2%

Timeline

Start date
2010-11-01
Primary completion
2011-05-01
Completion
2011-05-01
First posted
2010-10-25
Last updated
2017-10-05
Results posted
2013-07-22

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01228071. Inclusion in this directory is not an endorsement.